Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ubiquinone | 3 | 2021 | 188 | 0.880 |
Why?
|
| Shock, Septic | 8 | 2023 | 775 | 0.800 |
Why?
|
| Heart Arrest | 9 | 2021 | 1470 | 0.630 |
Why?
|
| Emergency Service, Hospital | 13 | 2018 | 7659 | 0.580 |
Why?
|
| Thiamine | 5 | 2023 | 152 | 0.560 |
Why?
|
| Hospital Mortality | 9 | 2018 | 5317 | 0.390 |
Why?
|
| Dizziness | 1 | 2014 | 251 | 0.390 |
Why?
|
| Chest Pain | 3 | 2007 | 1114 | 0.360 |
Why?
|
| Vertigo | 1 | 2011 | 202 | 0.340 |
Why?
|
| Cytochromes c | 3 | 2019 | 180 | 0.330 |
Why?
|
| Lactic Acid | 6 | 2020 | 1133 | 0.320 |
Why?
|
| Influenza, Human | 1 | 2018 | 1479 | 0.300 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2020 | 339 | 0.290 |
Why?
|
| Bacteremia | 1 | 2012 | 962 | 0.260 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 460 | 0.240 |
Why?
|
| Respiratory Insufficiency | 3 | 2017 | 1199 | 0.230 |
Why?
|
| Sepsis | 7 | 2017 | 2593 | 0.230 |
Why?
|
| Thiamine Deficiency | 2 | 2016 | 43 | 0.220 |
Why?
|
| Cardiopulmonary Resuscitation | 6 | 2020 | 980 | 0.220 |
Why?
|
| Angina Pectoris | 1 | 2006 | 977 | 0.200 |
Why?
|
| Propanolamines | 1 | 2022 | 167 | 0.200 |
Why?
|
| Stroke | 4 | 2017 | 9981 | 0.190 |
Why?
|
| Vasoconstrictor Agents | 3 | 2022 | 642 | 0.180 |
Why?
|
| Myocardial Infarction | 5 | 2007 | 11727 | 0.180 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2020 | 147 | 0.170 |
Why?
|
| Neuromuscular Blockade | 1 | 2020 | 146 | 0.170 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 1257 | 0.170 |
Why?
|
| Vital Signs | 2 | 2017 | 142 | 0.160 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 390 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2020 | 651 | 0.150 |
Why?
|
| Community-Acquired Infections | 2 | 2018 | 465 | 0.150 |
Why?
|
| Electrocardiography | 2 | 2007 | 6442 | 0.140 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 126 | 0.140 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2017 | 188 | 0.140 |
Why?
|
| Middle Aged | 29 | 2020 | 213383 | 0.130 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12026 | 0.130 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2017 | 207 | 0.130 |
Why?
|
| Acute Disease | 2 | 2018 | 7149 | 0.120 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 15076 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2016 | 346 | 0.120 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 2886 | 0.120 |
Why?
|
| Angiopoietin-2 | 1 | 2015 | 173 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2017 | 23338 | 0.120 |
Why?
|
| Shock | 1 | 2016 | 318 | 0.110 |
Why?
|
| Intensive Care Units | 4 | 2019 | 3679 | 0.110 |
Why?
|
| Male | 31 | 2020 | 350118 | 0.110 |
Why?
|
| beta-Alanine | 1 | 2013 | 74 | 0.110 |
Why?
|
| Aged | 24 | 2020 | 163280 | 0.110 |
Why?
|
| Simvastatin | 1 | 2015 | 360 | 0.110 |
Why?
|
| Epinephrine | 1 | 2016 | 792 | 0.110 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 1972 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 612 | 0.110 |
Why?
|
| Withholding Treatment | 1 | 2016 | 599 | 0.110 |
Why?
|
| Micronutrients | 1 | 2015 | 375 | 0.100 |
Why?
|
| Prospective Studies | 10 | 2019 | 53288 | 0.100 |
Why?
|
| Female | 31 | 2020 | 380194 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2006 | 6077 | 0.100 |
Why?
|
| Pneumonia, Bacterial | 1 | 2014 | 316 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1401 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2012 | 270 | 0.090 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2012 | 232 | 0.090 |
Why?
|
| Antithrombins | 1 | 2013 | 304 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1130 | 0.090 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 57776 | 0.080 |
Why?
|
| Acidosis, Lactic | 1 | 2010 | 142 | 0.080 |
Why?
|
| Humans | 36 | 2023 | 744343 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 1541 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 788 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2016 | 1826 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2013 | 850 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3255 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2016 | 8324 | 0.070 |
Why?
|
| Risk Factors | 7 | 2017 | 72290 | 0.070 |
Why?
|
| Pneumonia | 1 | 2018 | 2133 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2016 | 2289 | 0.070 |
Why?
|
| Cause of Death | 1 | 2016 | 3584 | 0.070 |
Why?
|
| Critical Care | 1 | 2018 | 2647 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 687 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15540 | 0.060 |
Why?
|
| Warfarin | 1 | 2013 | 1496 | 0.060 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 2274 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 1400 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2020 | 77449 | 0.050 |
Why?
|
| Hypotension | 2 | 2018 | 884 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 3508 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2013 | 3461 | 0.050 |
Why?
|
| Adult | 7 | 2020 | 214055 | 0.050 |
Why?
|
| Hospitalization | 2 | 2018 | 10262 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7181 | 0.050 |
Why?
|
| Registries | 4 | 2017 | 8089 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 834 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12959 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
| Hypernatremia | 1 | 2020 | 82 | 0.040 |
Why?
|
| Logistic Models | 3 | 2016 | 13408 | 0.040 |
Why?
|
| Tachycardia | 1 | 2022 | 619 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2022 | 909 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 299 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10638 | 0.040 |
Why?
|
| Cross Infection | 2 | 2020 | 1416 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2011 | 9849 | 0.040 |
Why?
|
| Creatinine | 1 | 2023 | 1919 | 0.040 |
Why?
|
| Age Factors | 2 | 2013 | 18370 | 0.040 |
Why?
|
| Uremia | 1 | 2018 | 201 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2017 | 40561 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2018 | 162 | 0.040 |
Why?
|
| Prognosis | 3 | 2019 | 29063 | 0.040 |
Why?
|
| Confusion | 1 | 2018 | 275 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10252 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 2020 | 752 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2007 | 4577 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2016 | 3508 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 345 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2618 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12354 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 229 | 0.030 |
Why?
|
| Electric Countershock | 1 | 2016 | 534 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 707 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2017 | 1184 | 0.030 |
Why?
|
| Survival Rate | 2 | 2017 | 12788 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 56430 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2022 | 4199 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2020 | 1373 | 0.020 |
Why?
|
| Time Factors | 3 | 2019 | 40075 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 2682 | 0.020 |
Why?
|
| Interleukins | 1 | 2015 | 791 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3778 | 0.020 |
Why?
|
| Age Distribution | 1 | 2016 | 2902 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
| ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
| United States | 4 | 2020 | 69872 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 1869 | 0.020 |
Why?
|
| Comorbidity | 2 | 2017 | 10388 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2010 | 179 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1781 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2016 | 1904 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7279 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20129 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7186 | 0.020 |
Why?
|
| Consensus | 1 | 2016 | 2959 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2017 | 6459 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2009 | 499 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
| Survivors | 1 | 2017 | 2291 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2266 | 0.020 |
Why?
|
| Cholesterol | 1 | 2015 | 2917 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2569 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8340 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 4420 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2019 | 3749 | 0.020 |
Why?
|
| Massachusetts | 1 | 2017 | 8663 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 35421 | 0.010 |
Why?
|
| Inpatients | 1 | 2015 | 2518 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12245 | 0.010 |
Why?
|
| Hospitals | 1 | 2016 | 3952 | 0.010 |
Why?
|
| Cytokines | 1 | 2016 | 7322 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6309 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 9959 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15226 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
| Incidence | 1 | 2016 | 20947 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21746 | 0.010 |
Why?
|
| Critical Illness | 1 | 2010 | 2670 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 21827 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39050 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9687 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 5034 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 81183 | 0.000 |
Why?
|
| Animals | 1 | 2015 | 168757 | 0.000 |
Why?
|
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_